Intrinsiqq
Burzynski Research Institute Inc. logo

Burzynski Research Institute Inc.

BZYR

Compare
⚠ Showing the latest available close (Nov 19, 2026, 3 days ago). Our price provider hasn't published a newer EOD for this ticker yet. Price-dependent metrics (P/E, P/FCF, yield) may not reflect current market conditions.

Valuation & Multiples

Based on TTM earnings · Diluted shares

Market Cap$26K
EPS-$0.01
P/E-0.02
P/FCF–
EV/EBITDA-0.02
FCF Yield–
Div. Yield–
Net Debt/FCF–
Burzynski Research Institute Inc. intrinsic value

Profitability & Returns

Revenue (TTM)

$0.00

Net Income (TTM)

-$1M

▼ -3.8% YoY

Op. Margin

–

ROIC

–

Cash Flow & Balance Sheet

FCF

N/A

Op. Cash Flow (TTM)

-$258K

▲ +25.8% YoY

Net Debt

-$2K

Net Cash Position

Cash & Equiv.

$2K

Continue Research

Peers

In Vitro & In Vivo Diagnostic Substances · Pick stocks to compare with BZYR

CompareIntrinsic value
BMRABiomerica Inc.
$1.08-1.82%25
AWHLAspira Women's Health Inc.
No recent price0
ICCCImmuCell Corporation
$10.92-2.24%69
VNRXVolitionRx Limited
$0.16+0.00%30
IMDXInsight Molecular Diagnostics Inc.
$1.96+18.07%25
CDIOCardio Diagnostics Holdings Inc.
$1.60-3.03%30
QDELQuidelOrtho Corporation
$8.32-6.73%0
NTLAIntellia Therapeutics Inc.
$10.00+5.04%25

Burzynski Research Institute (BZYR) in three numbers

Quality score
18/100
Best check: net debt, -$2165. Weakest: share count change, 0.0%.
Quality
Dividend
None
No dividend in the SEC filings we hold.
Dividends
P/E
-0.02
Negative: a loss over the last twelve months.
Financials

Questions about Burzynski Research Institute

Is Burzynski Research Institute a high-quality business?

Burzynski Research Institute scores 18 out of 100 on Intrinsiqq's quality score, which makes it a lower-quality business on these measures. The score blends 2 checks computed from SEC filings. Its best check is net debt at -$2165, and its weakest is share count change at 0.0%. The Quality tab shows every check against its target.

Does Burzynski Research Institute (BZYR) pay a dividend?

No. Burzynski Research Institute (BZYR) does not pay a dividend, and no dividend payment appears anywhere in the filing history we hold. Nor has its share count fallen meaningfully over the last twelve months, so cash is kept in the business. The Dividends tab shows its cash returns.

Source: 10-Q filed 13 Jan 2026 (period ending 30 Nov 2025), SEC. Price: last close 19 Nov 2026. How this is calculated. Sector medians are approximate S&P 500 benchmarks and update periodically. Analysis, not investment advice.

Spot a number that looks wrong? Check it in BZYR's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing BZYR

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

MarketsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.